FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
Multi-ancestry genetic score improves risk prediction for Alzheimer’s disease
Late-onset Alzheimer disease (AD) is a progressive disorder characterized by cognitive decline and memory impairment, affecting an estimated…
HHS plans new FDA leadership roles for technology, drugs
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health…
How AI is changing the pharmaceuticals landscape
Nintedanib, a widely used drug for pulmonary fibrosis, received official approval in 2014 after its development began in…
Lil Nas X’s bipolar diagnosis and mental health treatment| STAT
When Lil Nas X recently disclosed that he had been diagnosed with bipolar disorder, one part of his…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Laser treatment may extend survival in glioblastoma patients
For patients facing a diagnosis of glioblastoma – one of the most aggressive and devastating forms of brain…
Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’
Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…
Lilly sues six firms over alleged illegal sales of obesity drug retatrutide
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
Stopping statins at 75 may be safe for healthy adults, Lancet study says
Not long after guidelines shifted to considering statin therapy as early as age 30, new research from France…
Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…
Eli Lilly (LLY) earnings Q2 2026
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…